PRISM BioLab and Elix Collaborate on AI-Driven Drug Discovery
PRISM BioLab and Elix have announced a strategic collaboration to accelerate drug discovery for protein-protein interaction (PPI) targets, announced in a press release. This partnership, effective from April 1, 2025, aims to combine PRISM BioLab's peptide mimetic technology with Elix's AI drug discovery platform to create a novel drug discovery pipeline.
The collaboration seeks to address the challenges of generating clinical candidate molecules, which traditionally require synthesizing numerous compounds. By integrating PRISM BioLab's PepMetics® technology with Elix's AI platform, the partnership aims to efficiently identify promising compounds for difficult targets, thereby accelerating the creation of breakthrough drug candidates. This approach is expected to reduce time and costs while improving the success rate of drug discovery, ultimately delivering innovative treatments for unmet medical needs.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 LateralCare brings revenue alai to Microsoft Marketplace Sep 30 NYU Langone Tests AI Tool to Fill Radiology Training Gaps Sep 30 Healthcare Triangle Plans North American Humanoid Nursing Robot Venture Sep 30 Xtalks Plans Webinar on AI Governance in Clinical Development Sep 30 Suvoda Updates Clinical Trial Platform With AI and Unified AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
EpiVax Adds AI Models to ISPRI Immunogenicity Platform
AbbVie Partners With Valkai on AI Tools for Clinical Development
Elsevier Adds LG AI Vision Technology to Reaxys
Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354
Standigm and Protai Start AI Molecular Glue Research Program
Daily AI Brief: the AI news that matters, in your inbox.